{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:03:28Z","timestamp":1791219808275,"version":"4.1.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s11095-008-9559-6","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T19:15:24Z","timestamp":1205349324000},"page":"1256-1273","source":"Crossref","is-referenced-by-count":169,"title":["Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities"],"prefix":"10.1007","volume":"25","author":[{"given":"J-P.","family":"Amorij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Huckriede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wilschut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. L. J.","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,3,13]]},"reference":[{"key":"9559_CR1","unstructured":"WHO. WHO Media Influenza Factsheet No. 211. (2003)."},{"key":"9559_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.28.399","volume":"28","author":"Y. Suzuki","year":"2005","unstructured":"Y. Suzuki. Sialobiology of influenza: Molecular mechanism of host range variation of influenza viruses. Biol. Pharm. Bull. 28:399\u2013408 (2005).","journal-title":"Biol. Pharm. Bull."},{"key":"9559_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1473-3099(04)01105-3","volume":"4","author":"I. Stephenson","year":"2004","unstructured":"I. Stephenson, K. G. Nicholson, J. M. Wood, M. C. Zambon, and J. M. Katz. Confronting the avian influenza threat: Vaccine development for a potential pandemic. Lancet Infect. Dis. 4:499\u2013509 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"9559_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","volume":"59","author":"R. J. Cox","year":"2004","unstructured":"R. J. Cox, K. A. Brokstad, and P. Ogra. Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand. J. Immunol. 59:1\u201315 (2004).","journal-title":"Scand. J. Immunol."},{"key":"9559_CR5","unstructured":"The European Agency for the Evaluation of Medicinal Products (EMEA) Committee for Proprietary Medicinal Products (CPMP). Guideline on Dossier Structure and Content for Pandemic Influenza Vaccine Marketing Authorisation Application. CPMP\/VEG\/4717\/03 (2004)."},{"key":"9559_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2005.12.003","volume":"58","author":"E. L. Giudice","year":"2006","unstructured":"E. L. Giudice, and J. D. Campbell. Needle-free vaccine delivery. Adv. Drug Deliv. Rev. 58:68\u201389 (2006).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9559_CR7","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","volume":"23","author":"L. C. Freytag","year":"2005","unstructured":"L. C. Freytag, and J. D. Clements. Mucosal adjuvants. Vaccine 23:1804\u20131813 (2005).","journal-title":"Vaccine"},{"key":"9559_CR8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J. Holmgren","year":"2005","unstructured":"J. Holmgren, and C. Czerkinsky. Mucosal immunity and vaccines. Nat. Med. 11:S45\u2013S53 (2005).","journal-title":"Nat. Med."},{"key":"9559_CR9","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/S0264-410X(03)00224-X","volume":"21","author":"D. J. Smith","year":"2003","unstructured":"D. J. Smith, S. Bot, L. Dellamary, and A. Bot. Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. Vaccine 21:2805\u20132812 (2003).","journal-title":"Vaccine"},{"key":"9559_CR10","volume-title":"Rapid Reference Influenza","author":"J. Wilschut","year":"2006","unstructured":"J. Wilschut, J. E. McElhaney, and A. M. Palache. Rapid Reference Influenza. Mosby\/Elsevier Science, London, 2006."},{"key":"9559_CR11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","volume":"8","author":"I. A. Wilson","year":"1990","unstructured":"I. A. Wilson, and N. J. Cox. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737\u2013771 (1990).","journal-title":"Annu. Rev. Immunol."},{"key":"9559_CR12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/289373a0","volume":"289","author":"D. C. Wiley","year":"1981","unstructured":"D. C. Wiley, I. A. Wilson, and J. J. Skehel. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373\u2013378 (1981).","journal-title":"Nature"},{"key":"9559_CR13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00216-004-2927-0","volume":"381","author":"Y. Amano","year":"2005","unstructured":"Y. Amano, and Q. Cheng. Detection of influenza virus: traditional approaches and development of biosensors. Anal. Bioanal. Chem. 381:156\u2013164 (2005).","journal-title":"Anal. Bioanal. Chem."},{"key":"9559_CR14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.spid.2005.07.002","volume":"16","author":"B. L. Ligon","year":"2005","unstructured":"B. L. Ligon. Avian influenza virus H5N1: A review of its history and information regarding its potential to cause the next pandemic. Semin. Pediatr. Infect. Dis. 16:326\u2013335 (2005).","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"9559_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3201\/eid1201.050983","volume":"12","author":"A. S. Fauci","year":"2006","unstructured":"A. S. Fauci. Pandemic influenza threat and preparedness. Emerg. Infect. Dis. 12:73\u201377 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"9559_CR16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1378\/chest.129.1.156","volume":"129","author":"S. S. Wong","year":"2006","unstructured":"S. S. Wong, and K. Y. Yuen. Avian influenza virus infections in humans. Chest 129:156\u2013168 (2006).","journal-title":"Chest"},{"key":"9559_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3201\/eid1201.051147","volume":"12","author":"C. J. Luke","year":"2006","unstructured":"C. J. Luke, and K. Subbarao. Vaccines for pandemic influenza. Emerg. Infect. Dis. 12:66\u201372 (2006).","journal-title":"Emerg Infect Dis."},{"key":"9559_CR18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/14760584.3.6.643","volume":"3","author":"R. Belshe","year":"2004","unstructured":"R. Belshe, M. S. Lee, R. E. Walker, J. Stoddard, and P. M. Mendelman. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev. Vaccines 3:643\u2013654 (2004).","journal-title":"Expert Rev Vaccines."},{"key":"9559_CR19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/00006454-199912000-00017","volume":"18","author":"J. S. Abramson","year":"1999","unstructured":"J. S. Abramson. Intranasal, cold-adapted, live, attenuated influenza vaccine. Pediatr. Infect. Dis. J. 18:1103\u20131104 (1999).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"9559_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0264-410X(00)00153-5","volume":"19","author":"L. G. Rudenko","year":"2000","unstructured":"L. G. Rudenko, N. H. Arden, E. Grigorieva, A. Naychin, A. Rekstin, A. I. Klimov, S. Donina, J. Desheva, R. C. Holman, A. DeGuzman, N. J. Cox, and J. M. Katz. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine 19:308\u2013318 (2000).","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"9559_CR21","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2005.04.026","volume":"23","author":"A. Huckriede","year":"2005","unstructured":"A. Huckriede, L. Bungener, T. Stegmann, T. Daemen, J. Medema, A. M. Palache, and J. Wilschut. The virosome concept for influenza vaccines. Vaccine. 23(Suppl 1):S26\u2013S38 (2005).","journal-title":"Vaccine"},{"key":"9559_CR22","first-page":"93","volume":"98","author":"R. Brands","year":"1999","unstructured":"R. Brands, J. Visser, J. Medema, A. M. Palache, and G. J. van Scharrenburg. Influvac: A safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine. Dev. Biol. Stand. 98:93\u2013100 (1999) discussion 111.","journal-title":"Dev. Biol. Stand."},{"key":"9559_CR23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0264-410X(97)00301-0","volume":"16","author":"O. Kistner","year":"1998","unstructured":"O. Kistner, P. N. Barrett, W. Mundt, M. Reiter, S. Schober-Bendixen, and F. Dorner. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 16:960\u2013968 (1998).","journal-title":"Vaccine"},{"key":"9559_CR24","first-page":"115","volume":"98","author":"A. M. Palache","year":"1999","unstructured":"A. M. Palache, H. S. Scheepers, V. de Regt, P. van Ewijk, M. Baljet, R. Brands, and G. J. van Scharrenburg. Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies. Dev. Biol. Stand. 98:115\u2013125 (1999) discussion 133\u2013134.","journal-title":"Dev. Biol. Stand."},{"key":"9559_CR25","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","volume":"19","author":"M. G. Pau","year":"2001","unstructured":"M. G. Pau, C. Ophorst, M. H. Koldijk, G. Schouten, M. Mehtali, and F. Uytdehaag. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 19:2716\u20132721 (2001).","journal-title":"Vaccine"},{"key":"9559_CR26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0264-410X(93)90197-6","volume":"11","author":"E. I. Budowsky","year":"1993","unstructured":"E. I. Budowsky, A. Smirnov Yu, and S. F. Shenderovich. Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virus. Vaccine 11:343\u2013348 (1993).","journal-title":"Vaccine"},{"key":"9559_CR27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/oxfordjournals.aje.a112272","volume":"104","author":"D. W. Barry","year":"1976","unstructured":"D. W. Barry, R. E. Mayner, E. Staton, R. C. Dunlap, S. C. Rastogi, J. E. Hannah, R. J. Blackburn, D. F. Nortman, and P. R. Graze. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Am. J. Epidemiol. 104:34\u201346 (1976).","journal-title":"Am. J. Epidemiol."},{"key":"9559_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/136.5.623","volume":"136","author":"P. A. Gross","year":"1977","unstructured":"P. A. Gross, F. A. Ennis, P. F. Gaerlan, L. J. Denson, C. R. Denning, and D. Schiffman. A controlled double-blind comparison of reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J. Infect. Dis. 136:623\u2013632 (1977).","journal-title":"J. Infect. Dis."},{"key":"9559_CR29","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1016\/j.vaccine.2006.05.040","volume":"24","author":"R. J. Cox","year":"2006","unstructured":"R. J. Cox, A. O. Hovden, K. A. Brokstad, E. Szyszko, A. S. Madhun, and L. R. Haaheim. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB\/c mice. Vaccine 24:6585\u20136587 (2006).","journal-title":"Vaccine"},{"issue":"Pt 2","key":"9559_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1099\/0022-1317-68-2-441","volume":"68","author":"R. Jennings","year":"1987","unstructured":"R. Jennings, R. M. Pemberton, T. L. Smith, T. Amin, and C. W. Potter. Demonstration of an immunosuppressive action of detergent-disrupted influenza virus on the antibody response to inactivated whole virus vaccine. J. Gen. Virol. 68(Pt 2):441\u2013450 (1987).","journal-title":"J. Gen. Virol."},{"key":"9559_CR31","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.125.5.2182","volume":"125","author":"C. S. Reiss","year":"1980","unstructured":"C. S. Reiss, and J. L. Schulman. Cellular immune responses of mice to influenza virus vaccines. J. Immunol. 125:2182\u20132188 (1980).","journal-title":"J. Immunol."},{"key":"9559_CR32","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1016\/j.vaccine.2006.05.039","volume":"24","author":"X. Lu","year":"2006","unstructured":"X. Lu, L. E. Edwards, J. A. Desheva, D. C. Nguyen, A. Rekstin, I. Stephenson, K. Szretter, N. J. Cox, L. G. Rudenko, A. Klimov, and J. M. Katz. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. Vaccine. 24:6588\u20136593 (2006).","journal-title":"Vaccine"},{"key":"9559_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(81)91389-1","volume":"2","author":"F. A. Ennis","year":"1981","unstructured":"F. A. Ennis, A. H. Rook, Y. H. Qi, G. C. Schild, D. Riley, R. Pratt, and C. W. Potter. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet. 2:887\u2013891 (1981).","journal-title":"Lancet"},{"key":"9559_CR34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.159.2.365","volume":"159","author":"U. Kees","year":"1984","unstructured":"U. Kees, and P. H. Krammer. Most influenza A virus-specific memory cytotoxic T lymphocytes react with antigenic epitopes associated with internal virus determinants. J. Exp. Med. 159:365\u2013377 (1984).","journal-title":"J. Exp. Med."},{"key":"9559_CR35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1183\/09031936.01.00084301","volume":"17","author":"I. Stephenson","year":"2001","unstructured":"I. Stephenson, and K. G. Nicholson. Influenza: Vaccination and treatment. Eur. Respir. J. 17:1282\u201312893 (2001).","journal-title":"Eur. Respir. J."},{"key":"9559_CR36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.coph.2007.06.004","volume":"7","author":"W. A. Keitel","year":"2007","unstructured":"W. A. Keitel, and R. L. Atmar. Preparing for a possible pandemic: Influenza A\/H5N1 vaccine development. Curr. Opin. Pharmacol. 7:484\u2013490 (2007).","journal-title":"Curr. Opin. Pharmacol."},{"key":"9559_CR37","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/j.1460-2075.1987.tb02556.x","volume":"6","author":"T. Stegmann","year":"1987","unstructured":"T. Stegmann, H. W. Morselt, F. P. Booy, J. F. van Breemen, G. Scherphof, and J. Wilschut. Functional reconstitution of influenza virus envelopes. Embo J. 6:2651\u20132659 (1987).","journal-title":"Embo J."},{"key":"9559_CR38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0076-6879(93)20091-G","volume":"220","author":"R. Bron","year":"1993","unstructured":"R. Bron, A. Ortiz, J. Dijkstra, T. Stegmann, and J. Wilschut. Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes). Methods Enzymol. 220:313\u2013331 (1993).","journal-title":"Methods Enzymol."},{"key":"9559_CR39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbamem.2006.03.011","volume":"1758","author":"J. Jonge de","year":"2006","unstructured":"J. de Jonge, P. Schoen, W. ter Veer, T. Stegmann, J. Wilschut, and A. Huckriede. Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes. Biochim. Biophys. Acta. 1758:527\u2013536 (2006).","journal-title":"Biochim. Biophys. Acta."},{"issue":"Suppl 1","key":"9559_CR40","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.vaccine.2005.04.020","volume":"23","author":"I. A. Bruijn de","year":"2005","unstructured":"I. A. de Bruijn, J. Nauta, W. C. Cramer, L. Gerez, and A. M. Palache. Clinical experience with inactivated, virosomal influenza vaccine. Vaccine 23(Suppl 1):S39\u2013S49 (2005).","journal-title":"Vaccine"},{"key":"9559_CR41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vaccine.2007.10.051","volume":"26","author":"I. Bruijn de","year":"2007","unstructured":"I. de Bruijn, I. Meyer, L. Gerez, J. Nauta, K. Giezeman, and B. Palache. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 26:119\u2013127 (2007).","journal-title":"Vaccine"},{"key":"9559_CR42","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","volume":"20","author":"W. E. Beyer","year":"2002","unstructured":"W. E. Beyer, A. M. Palache, J. C. de Jong, and A. D. Osterhaus. Cold-adapted live influenza vaccine versus inactivated vaccine: Systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 20:1340\u20131353 (2002).","journal-title":"Vaccine"},{"key":"9559_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","volume":"24","author":"M. L. Clements","year":"1986","unstructured":"M. L. Clements, R. F. Betts, E. L. Tierney, and B. R. Murphy. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24:157\u2013160 (1986).","journal-title":"J. Clin. Microbiol."},{"key":"9559_CR44","unstructured":"WHO Department of Immunization, Vaccines and Biologicals. Temperature sensitivity of vaccines. (2006)."},{"key":"9559_CR45","unstructured":"ICH, Q1A (R2). Stability testing guidelines: Stability testing of new drug substances and products. ICH step 5. CPMP\/ICH\/2736\/99."},{"key":"9559_CR46","unstructured":"ICH, Q5C. Stability testing of biotechnological\/biological products. ICH step 4. CPMP\/ICH\/138\/95."},{"key":"9559_CR47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.vaccine.2005.07.081","volume":"24","author":"F. Coenen","year":"2006","unstructured":"F. Coenen, J. T. Tolboom, and H. W. Frijlink. Stability of influenza sub-unit vaccine. Does a couple of days outside the refrigerator matter? Vaccine 24:525\u2013531 (2006).","journal-title":"Vaccine"},{"key":"9559_CR48","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1128\/AAC.00517-07","volume":"51","author":"S. L. Block","year":"2007","unstructured":"S. L. Block, K. S. Reisinger, M. Hultquist, and R. E. Walker. Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects. Antimicrob. Agents Chemother. 51:4001\u20134008 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9559_CR49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2004.05.007","volume":"23","author":"D. M. Luykx","year":"2004","unstructured":"D. M. Luykx, M. G. Casteleijn, W. Jiskoot, J. Westdijk, and P. M. Jongen. Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material. Eur. J. Pharm. Sci. 23:65\u201375 (2004).","journal-title":"Eur. J. Pharm. Sci."},{"key":"9559_CR50","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1016\/j.vaccine.2007.06.054","volume":"25","author":"J. P. Amorij","year":"2007","unstructured":"J. P. Amorij, J. Meulenaar, W. L. Hinrichs, T. Stegmann, A. Huckriede, F. Coenen, and H. W. Frijlink. Rational design of an influenza subunit vaccine powder with sugar glass technology: Preventing conformational changes of haemagglutinin during freezing and freeze-drying. Vaccine 25:6447\u20136457 (2007).","journal-title":"Vaccine"},{"key":"9559_CR51","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1016\/j.vaccine.2006.05.007","volume":"24","author":"S. E. Zweig","year":"2006","unstructured":"S. E. Zweig. Advances in vaccine stability monitoring technology. Vaccine 24:5977\u20135985 (2006).","journal-title":"Vaccine"},{"key":"9559_CR52","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1016\/j.vaccine.2004.10.053","volume":"23","author":"J. S. Oxford","year":"2005","unstructured":"J. S. Oxford, C. Manuguerra, O. Kistner, A. Linde, M. Kunze, W. Lange, B. Schweiger, G. Spala, H. Rebelo de Andrade, P. R. Perez Brena, J. Beytout, L. Brydak, D. Caraffa de Stefano, O. Hungnes, J. Kyncl, E. Montomoli, A. Gil de Miguel, R. Vranckx, and A. Osterhaus. A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. Vaccine 23:5440\u20135449 (2005).","journal-title":"Vaccine"},{"key":"9559_CR53","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2007.05.033","volume":"25","author":"A. D. Osterhaus","year":"2007","unstructured":"A. D. Osterhaus. Pre- or post-pandemic influenza vaccine? Vaccine 25:4983\u20134984 (2007).","journal-title":"Vaccine"},{"key":"9559_CR54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1474-4422(04)00928-7","volume":"3","author":"P. E. Fine","year":"2004","unstructured":"P. E. Fine. Poliomyelitis: Very small risks and very large risks. Lancet Neurol. 3:703 (2004).","journal-title":"Lancet Neurol."},{"key":"9559_CR55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","volume":"5","author":"S. Mitragotri","year":"2005","unstructured":"S. Mitragotri. Immunization without needles. Nat. Rev. Immunol. 5:905\u2013916 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"9559_CR56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.1830140414","volume":"14","author":"F. Y. Liew","year":"1984","unstructured":"F. Y. Liew, S. M. Russell, G. Appleyard, C. M. Brand, and J. Beale. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:350\u2013356 (1984).","journal-title":"Eur. J. Immunol."},{"key":"9559_CR57","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","volume":"75","author":"T. M. Tumpey","year":"2001","unstructured":"T. M. Tumpey, M. Renshaw, J. D. Clements, and J. M. Katz. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol. 75:5141\u20135150 (2001).","journal-title":"J. Virol."},{"key":"9559_CR58","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1021\/js970135b","volume":"86","author":"T. W. Randolph","year":"1997","unstructured":"T. W. Randolph. Phase separation of excipients during lyophilization: Effects on protein stability. J. Pharm. Sci. 86:1198\u20131203 (1997).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/bp970093x","volume":"13","author":"C. Schebor","year":"1997","unstructured":"C. Schebor, L. Burin, M. P. Buera, J. M. Aguilera, and J. Chirife. Glassy state and thermal inactivation of invertase and lactase in dried amorphous matrices. Biotechnol. Prog. 13:857\u2013863 (1997).","journal-title":"Biotechnol. Prog."},{"key":"9559_CR60","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1351\/pac198860121841","volume":"60","author":"L. Slade","year":"1988","unstructured":"L. Slade, and H. Levine. Non-equilibrium behavior of small carbohydrate-water systems. Pure Appl. Chem. 60:1841\u20131864 (1988).","journal-title":"Pure Appl. Chem."},{"key":"9559_CR61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0260-8774(95)90766-5","volume":"24","author":"L. Slade","year":"1995","unstructured":"L. Slade, and H. Levine. Water and the glass transition: dependance of the glass transition on the composition and chemical structure: Special implications for flour functionality in cooky baking. J. Food Eng. 24:431\u2013509 (1995).","journal-title":"J. Food Eng."},{"key":"9559_CR62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-5173(00)00677-3","volume":"215","author":"W. L. Hinrichs","year":"2001","unstructured":"W. L. Hinrichs, M. G. Prinsen, and H. W. Frijlink. Inulin glasses for the stabilization of therapeutic proteins. Int. J. Pharm. 215:163\u2013174 (2001).","journal-title":"Int. J. Pharm."},{"key":"9559_CR63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-5173(02)00531-8","volume":"249","author":"H. J. Eriksson","year":"2002","unstructured":"H. J. Eriksson, W. L. Hinrichs, B. van Veen, G. W. Somsen, G. J. de Jong, and H. W. Frijlink. Investigations into the stabilisation of drugs by sugar glasses: I. Tablets prepared from stabilised alkaline phosphatase. Int. J. Pharm. 249:59\u201370 (2002).","journal-title":"Int. J. Pharm."},{"key":"9559_CR64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/glycob\/12.2.103","volume":"12","author":"D. K. Hincha","year":"2002","unstructured":"D. K. Hincha, E. Zuther, E. M. Hellwege, and A. G. Heyer. Specific effects of fructo- and gluco-oligosaccharides in the preservation of liposomes during drying. Glycobiology. 12:103\u2013110 (2002).","journal-title":"Glycobiology"},{"key":"9559_CR65","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0006-3495(96)79740-0","volume":"70","author":"W. Q. Sun","year":"1996","unstructured":"W. Q. Sun, A. C. Leopold, L. M. Crowe, and J. H. Crowe. Stability of dry liposomes in sugar glasses. Biophys. J. 70:1769\u20131776 (1996).","journal-title":"Biophys. J."},{"key":"9559_CR66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0003-9861(85)90498-9","volume":"242","author":"L. M. Crowe","year":"1985","unstructured":"L. M. Crowe, J. H. Crowe, A. Rudolph, C. Womersley, and L. Appel. Preservation of freeze-dried liposomes by trehalose. Arch. Biochem. Biophys. 242:240\u2013247 (1985).","journal-title":"Arch. Biochem. Biophys."},{"key":"9559_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2420001","volume":"242","author":"J. H. Crowe","year":"1987","unstructured":"J. H. Crowe, L. M. Crowe, J. F. Carpenter, and C. Aurell Wistrom. Stabilization of dry phospholipid bilayers and proteins by sugars. Biochem. J. 242:1\u201310 (1987).","journal-title":"Biochem. J."},{"key":"9559_CR68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2004.12.011","volume":"103","author":"W. L. Hinrichs","year":"2005","unstructured":"W. L. Hinrichs, N. N. Sanders, S. C. De Smedt, J. Demeester, and H. W. Frijlink. Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes. J. Control. Release. 103:465\u2013479 (2005).","journal-title":"J. Control. Release"},{"key":"9559_CR69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijpharm.2005.12.032","volume":"311","author":"W. L. Hinrichs","year":"2006","unstructured":"W. L. Hinrichs, F. A. Mancenido, N. N. Sanders, K. Braeckmans, S. C. De Smedt, J. Demeester, and H. W. Frijlink. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int. J. Pharm. 311:237\u2013244 (2006).","journal-title":"Int. J. Pharm."},{"key":"9559_CR70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-0934(01)00432-3","volume":"102","author":"D. A. Yannarell","year":"2002","unstructured":"D. A. Yannarell, K. M. Goldberg, and R. N. Hjorth. Stabilizing cold-adapted influenza virus vaccine under various storage conditions. J. Virol. Methods. 102:15\u201325 (2002).","journal-title":"J. Virol. Methods"},{"key":"9559_CR71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-0934(82)90006-4","volume":"5","author":"J. A. Levy","year":"1982","unstructured":"J. A. Levy, and A. H. Fieldsteel. Freeze-drying is an effective method for preserving infectious type C retroviruses. J. Virol. Methods. 5:165\u2013171 (1982).","journal-title":"J. Virol. Methods"},{"key":"9559_CR72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/bp980057d","volume":"14","author":"R. M. Bieganski","year":"1998","unstructured":"R. M. Bieganski, A. Fowler, J. R. Morgan, and M. Toner. Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose. Biotechnol. Prog. 14:615\u2013620 (1998).","journal-title":"Biotechnol. Prog."},{"key":"9559_CR73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/10837459809009865","volume":"3","author":"M. A. Croyle","year":"1998","unstructured":"M. A. Croyle, B. J. Roessler, B. L. Davidson, J. M. Hilfinger, and G. L. Amidon. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm. Dev. Technol. 3:373\u2013383 (1998).","journal-title":"Pharm. Dev. Technol."},{"key":"9559_CR74","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2736(00)00251-0","volume":"1468","author":"S. D. Allison","year":"2000","unstructured":"S. D. Allison, M. C. Molina, and T. J. Anchordoquy. Stabilization of lipid\/DNA complexes during the freezing step of the lyophilization process: The particle isolation hypothesis. Biochim. Biophys. Acta. 1468:127\u2013138 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"9559_CR75","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/jps.20138","volume":"93","author":"M. C. Molina","year":"2004","unstructured":"M. C. Molina, T. K. Armstrong, Y. Zhang, M. M. Patel, Y. K. Lentz, and T. J. Anchordoquy. The stability of lyophilized lipid\/DNA complexes during prolonged storage. J. Pharm. Sci. 93:2259\u20132273 (2004).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR76","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/bi00435a044","volume":"28","author":"J. F. Carpenter","year":"1989","unstructured":"J. F. Carpenter, and J. H. Crowe. An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. Biochemistry. 28:3916\u20133922 (1989).","journal-title":"Biochemistry"},{"key":"9559_CR77","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1016\/j.vaccine.2007.10.035","volume":"25","author":"J. P. Amorij","year":"2007","unstructured":"J. P. Amorij, V. Saluja, A. H. Petersen, W. L. Hinrichs, A. Huckriede, and H. W. Frijlink. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB\/c mice. Vaccine 25:8707\u20138717 (2007).","journal-title":"Vaccine"},{"key":"9559_CR78","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1016\/S0264-410X(03)00175-0","volume":"21","author":"D. Chen","year":"2003","unstructured":"D. Chen, R. Endres, Y. F. Maa, C. R. Kensil, P. Whitaker-Dowling, A. Trichel, J. S. Youngner, and L. G. Payne. Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine 21:2830\u20132836 (2003).","journal-title":"Vaccine"},{"key":"9559_CR79","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jps.20104","volume":"93","author":"Y. F. Maa","year":"2004","unstructured":"Y. F. Maa, M. Ameri, C. Shu, L. G. Payne, and D. Chen. Influenza vaccine powder formulation development: Spray-freeze-drying and stability evaluation. J. Pharm. Sci. 93:1912\u20131923 (2004).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR80","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0092-1157(84)80012-8","volume":"12","author":"V. Lazzell","year":"1984","unstructured":"V. Lazzell, R. H. Waldman, C. Rose, R. Khakoo, A. Jacknowitz, and S. Howard. Immunization against influenza in humans using an oral enteric-coated killed virus vaccine. J. Biol. Stand. 12:315\u2013321 (1984).","journal-title":"J. Biol. Stand."},{"key":"9559_CR81","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0168-3659(00)00330-8","volume":"70","author":"M. Singh","year":"2001","unstructured":"M. Singh, M. Briones, and D. T. O\u2019Hagan. A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. J. Control. Release. 70:267\u2013276 (2001).","journal-title":"J. Control. Release"},{"key":"9559_CR82","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/80538","volume":"6","author":"D. Chen","year":"2000","unstructured":"D. Chen, R. L. Endres, C. A. Erickson, K. F. Weis, M. W. McGregor, Y. Kawaoka, and L. G. Payne. Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice. Nat. Med. 6:1187\u20131190 (2000).","journal-title":"Nat. Med."},{"key":"9559_CR83","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/S0264-410X(02)00215-3","volume":"20","author":"D. Chen","year":"2002","unstructured":"D. Chen, R. L. Endres, C. A. Erickson, Y. F. Maa, and L. G. Payne. Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity. Vaccine 20:2671\u20132679 (2002).","journal-title":"Vaccine"},{"key":"9559_CR84","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0264-410X(95)00016-T","volume":"13","author":"Z. Moldoveanu","year":"1995","unstructured":"Z. Moldoveanu, M. L. Clements, S. J. Prince, B. R. Murphy, and J. Mestecky. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13:1006\u20131012 (1995).","journal-title":"Vaccine"},{"key":"9559_CR85","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","volume":"23","author":"J. Huang","year":"2004","unstructured":"J. Huang, R. J. Garmise, T. M. Crowder, K. Mar, C. R. Hwang, A. J. Hickey, J. A. Mikszta, and V. J. Sullivan. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine 23:794\u2013801 (2004).","journal-title":"Vaccine"},{"key":"9559_CR86","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1208\/pt070119","volume":"7","author":"R. J. Garmise","year":"2006","unstructured":"R. J. Garmise, K. Mar, T. M. Crowder, C. R. Hwang, M. Ferriter, J. Huang, J. A. Mikszta, V. J. Sullivan, and A. J. Hickey. Formulation of a dry powder influenza vaccine for nasal delivery. AAPS PharmSciTech. 7:E19 (2006).","journal-title":"AAPS PharmSciTech."},{"key":"9559_CR87","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1023\/A:1010988311640","volume":"18","author":"A. I. Bot","year":"2001","unstructured":"A. I. Bot, D. J. Smith, S. Bot, L. Dellamary, T. E. Tarara, S. Harders, W. Phillips, J. G. Weers, and C. M. Woods. Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine. Pharm. Res. 18:971\u2013979 (2001).","journal-title":"Pharm. Res."},{"key":"9559_CR88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejps.2007.05.112","volume":"32","author":"J. Jonge de","year":"2007","unstructured":"J. de Jonge, J. P. Amorij, W. L. Hinrichs, J. Wilschut, A. Huckriede, and H. W. Frijlink. Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. Eur. J. Pharm. Sci. 32:33\u201344 (2007).","journal-title":"Eur. J. Pharm. Sci."},{"key":"9559_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","volume":"203","author":"W. Wang","year":"2000","unstructured":"W. Wang. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 203:1\u201360 (2000).","journal-title":"Int. J. Pharm."},{"key":"9559_CR90","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s11095-006-9191-2","volume":"24","author":"A. M. Abdul-Fattah","year":"2007","unstructured":"A. M. Abdul-Fattah, V. Truong-Le, L. Yee, E. Pan, Y. Ao, D. S. Kalonia, and M. J. Pikal. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on Stability II: Stability of a vaccine. Pharm. Res. 24:715\u2013727 (2007).","journal-title":"Pharm. Res."},{"key":"9559_CR91","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00249-006-0116-0","volume":"36","author":"T. Korte","year":"2007","unstructured":"T. Korte, K. Ludwig, Q. Huang, P. S. Rachakonda, and A. Herrmann. Conformational change of influenza virus hemagglutinin is sensitive to ionic concentration. Eur. Biophys. J. 36:327\u2013335 (2007).","journal-title":"Eur. Biophys. J."},{"key":"9559_CR92","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1023\/A:1025762328267","volume":"20","author":"J. H. Eriksson","year":"2003","unstructured":"J. H. Eriksson, W. L. Hinrichs, G. J. de Jong, G. W. Somsen, and H. W. Frijlink. Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers. Pharm. Res. 20:1437\u20131443 (2003).","journal-title":"Pharm. Res."},{"key":"9559_CR93","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.addr.2006.07.010","volume":"58","author":"S. A. Shoyele","year":"2006","unstructured":"S. A. Shoyele, and S. Cawthorne. Particle engineering techniques for inhaled biopharmaceuticals. Adv. Drug. Deliv. Rev. 58:1009\u20131029 (2006).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"9559_CR94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08982100701536883","volume":"17","author":"J. Wilschut","year":"2007","unstructured":"J. Wilschut, J. de Jonge, A. Huckriede, J. P. Amorij, W. L. Hinrichs, and H. W. Frijlink. Preservation of influenza virosome structure and function during freeze-drying and storage. J. Liposome Res. 17:173\u2013182 (2007).","journal-title":"J. Liposome Res."},{"key":"9559_CR95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-5173(99)00226-4","volume":"188","author":"A. Millqvist-Fureby","year":"1999","unstructured":"A. Millqvist-Fureby, M. Malmsten, and B. Bergenstahl. Spray-drying of trypsin\u2014surface characterisation and activity preservation. Int. J. Pharm. 188:243\u2013253 (1999).","journal-title":"Int. J. Pharm."},{"key":"9559_CR96","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1007568511399","volume":"17","author":"M. Adler","year":"2000","unstructured":"M. Adler, M. Unger, and G. Lee. Surface composition of spray-dried particles of bovine serum albumin\/trehalose\/surfactant. Pharm. Res. 17:863\u2013870 (2000).","journal-title":"Pharm. Res."},{"key":"9559_CR97","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/js9800679","volume":"87","author":"H. R. Costantino","year":"1998","unstructured":"H. R. Costantino, J. D. Andya, P. A. Nguyen, N. Dasovich, T. D. Sweeney, S. J. Shire, C. C. Hsu, and Y. F. Maa. Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody. J. Pharm. Sci. 87:1406\u20131411 (1998).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR98","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1023\/B:PHAM.0000033003.17251.c3","volume":"21","author":"R. Surana","year":"2004","unstructured":"R. Surana, A. Pyne, and R. Suryanarayanan. Effect of preparation method on physical properties of amorphous trehalose. Pharm. Res. 21:1167\u20131176 (2004).","journal-title":"Pharm. Res."},{"key":"9559_CR99","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1021\/js980081l","volume":"87","author":"R. T. Forbes","year":"1998","unstructured":"R. T. Forbes, K. G. Davis, M. Hindle, J. G. Clarke, and J. Maas. Water vapor sorption studies on the physical stability of a series of spray-dried protein\/sugar powders for inhalation. J. Pharm. Sci. 87:1316\u20131321 (1998).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR100","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.20418","volume":"94","author":"J. Elversson","year":"2005","unstructured":"J. Elversson, and A. Millqvist-Fureby. Particle size and density in spray drying-effects of carbohydrate properties. J. Pharm. Sci. 94:2049\u20132060 (2005).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR101","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1023\/A:1021445608807","volume":"19","author":"Y. H. Liao","year":"2002","unstructured":"Y. H. Liao, M. B. Brown, T. Nazir, A. Quader, and G. P. Martin. Effects of sucrose and trehalose on the preservation of the native structure of spray-dried lysozyme. Pharm. Res. 19:1847\u20131853 (2002).","journal-title":"Pharm. Res."},{"key":"9559_CR102","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jconrel.2004.07.022","volume":"99","author":"C. Bosquillon","year":"2004","unstructured":"C. Bosquillon, P. G. Rouxhet, F. Ahimou, D. Simon, C. Culot, V. Preat, and R. Vanbever. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control. Release. 99:357\u2013367 (2004).","journal-title":"J. Control. Release"},{"key":"9559_CR103","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/js9804819","volume":"88","author":"S. Branchu","year":"1999","unstructured":"S. Branchu, R. T. Forbes, P. York, S. Petren, H. Nyqvist, and O. Camber. Hydroxypropyl-beta-cyclodextrin inhibits spray-drying-induced inactivation of beta-galactosidase. J. Pharm. Sci. 88:905\u2013911 (1999).","journal-title":"J. Pharm. Sci."},{"key":"9559_CR104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0008-6215(90)84102-Z","volume":"196","author":"P. D. Orford","year":"1990","unstructured":"P. D. Orford, R. Parker, and S. G. Ring. Aspects of the glass transition behaviour of mixtures of carbohydrates of low molecular weight. Carbohydr. Res. 196:11\u201318 (1990).","journal-title":"Carbohydr. Res."},{"key":"9559_CR105","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1023\/A:1018945117471","volume":"11","author":"A. Saleki-Gerhardt","year":"1994","unstructured":"A. Saleki-Gerhardt, and G. Zografi. Non-isothermal and isothermal crystallization of sucrose from the amorphous state. Pharm. Res. 11:1166\u20131173 (1994).","journal-title":"Pharm. Res."},{"key":"9559_CR106","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1021\/la0355186","volume":"20","author":"A. Aksan","year":"2004","unstructured":"A. Aksan, and M. Toner. Isothermal desiccation and vitrification kinetics of trehalose-dextran solutions. Langmuir. 20:5521\u20135529 (2004).","journal-title":"Langmuir"},{"key":"9559_CR107","first-page":"173","volume":"18","author":"U. B. Kompella","year":"2001","unstructured":"U. B. Kompella, and K. Koushik. Preparation of drug delivery systems using supercritical fluid technology. Crit. Rev. Ther. Drug Carrier Syst. 18:173\u2013199 (2001).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"9559_CR108","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1023\/B:PHAM.0000048185.09483.e7","volume":"21","author":"N. Jovanovic","year":"2004","unstructured":"N. Jovanovic, A. Bouchard, G. W. Hofland, G. J. Witkamp, D. J. Crommelin, and W. Jiskoot. Stabilization of proteins in dry powder formulations using supercritical fluid technology. Pharm. Res. 21:1955\u20131969 (2004).","journal-title":"Pharm. Res."},{"key":"9559_CR109","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1016\/j.vaccine.2007.05.064","volume":"25","author":"M. Amidi","year":"2007","unstructured":"M. Amidi, H. C. Pellikaan, H. Hirschberg, A. H. de Boer, D. J. Crommelin, W. E. Hennink, G. Kersten, and W. Jiskoot. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine 25:6818\u20136829 (2007).","journal-title":"Vaccine"},{"key":"9559_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jamp.2007.0657","volume":"21","author":"J. L. Burger","year":"2008","unstructured":"J. L. Burger, S. P. Cape, C. S. Braun, D. H. McAdams, J. A. Best, P. Bhagwat, P. Pathak, L. G. Rebits, and R. E. Sievers. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine. J. Aerosol. Med. 21:1\u201310 (2008).","journal-title":"J. Aerosol. Med."},{"key":"9559_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8446(98)00129-6","volume":"15","author":"E. Reverchon","year":"1999","unstructured":"E. Reverchon. Supercritical antisolvent precipitation of micro-and nano-particles. J. Supercrit. Fluids 15:1\u201321 (1999).","journal-title":"J. Supercrit. Fluids"},{"key":"9559_CR112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/abbi.1999.1175","volume":"365","author":"S. D. Allison","year":"1999","unstructured":"S. D. Allison, B. Chang, T. W. Randolph, and J. F. Carpenter. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch. Biochem. Biophys. 365:289\u2013298 (1999).","journal-title":"Arch. Biochem. Biophys."},{"key":"9559_CR113","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/S0006-3495(03)75104-2","volume":"84","author":"I. J. Vereyken","year":"2003","unstructured":"I. J. Vereyken, V. Chupin, F. A. Hoekstra, S. C. Smeekens, and B. de Kruijff. The effect of fructan on membrane lipid organization and dynamics in the dry state. Biophys. J. 84:3759\u20133766 (2003).","journal-title":"Biophys. J."},{"key":"9559_CR114","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/S0006-3495(03)74724-9","volume":"85","author":"I. J. Vereyken","year":"2003","unstructured":"I. J. Vereyken, V. Chupin, A. Islamov, A. Kuklin, D. K. Hincha, and B. de Kruijff. The effect of fructan on the phospholipid organization in the dry state. Biophys. J. 85:3058\u20133065 (2003).","journal-title":"Biophys. J."},{"key":"9559_CR115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/cryo.2001.2353","volume":"43","author":"J. H. Crowe","year":"2001","unstructured":"J. H. Crowe, L. M. Crowe, A. E. Oliver, N. Tsvetkova, W. Wolkers, and F. Tablin. The trehalose myth revisited: Introduction to a symposium on stabilization of cells in the dry state. Cryobiology. 43:89\u2013105 (2001).","journal-title":"Cryobiology"},{"key":"9559_CR116","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0005-2736(94)90343-3","volume":"1193","author":"K. L. Koster","year":"1994","unstructured":"K. L. Koster, M. S. Webb, G. Bryant, and D. V. Lynch. Interactions between soluble sugars and POPC (1-palmitoyl-2-oleoylphosphatidylcholine) during dehydration: Vitrification of sugars alters the phase behavior of the phospholipid. Biochim. Biophys. Acta. 1193:143\u2013150 (1994).","journal-title":"Biochim. Biophys. Acta"},{"key":"9559_CR117","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0006-3495(00)76741-5","volume":"78","author":"K. L. Koster","year":"2000","unstructured":"K. L. Koster, Y. P. Lei, M. Anderson, S. Martin, and G. Bryant. Effects of vitrified and nonvitrified sugars on phosphatidylcholine fluid-to-gel phase transitions. Biophys. J. 78:1932\u20131946 (2000).","journal-title":"Biophys. J."},{"key":"9559_CR118","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/cryo.1999.2195","volume":"39","author":"J. Wolfe","year":"1999","unstructured":"J. Wolfe, and G. Bryant. Freezing, drying, and\/or vitrification of membrane- solute-water systems. Cryobiology. 39:103\u2013129 (1999).","journal-title":"Cryobiology"},{"key":"9559_CR119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cryobiol.2004.06.001","volume":"49","author":"G. R. Satpathy","year":"2004","unstructured":"G. R. Satpathy, Z. Torok, R. Bali, D. M. Dwyre, E. Little, N. J. Walker, F. Tablin, J. H. Crowe, and N. M. Tsvetkova. Loading red blood cells with trehalose: A step towards biostabilization. Cryobiology. 49:123\u2013136 (2004).","journal-title":"Cryobiology"},{"key":"9559_CR120","unstructured":"Influenza Vaccine (Surface Antigen, Inactivated) European Pharmacopoeia, 5th ed, Council of Europe, Strasbourg, 2004, pp. 673\u2013674."},{"key":"9559_CR121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmv.10540","volume":"72","author":"S. Babiuk","year":"2004","unstructured":"S. Babiuk, D. M. Skowronski, G. De Serres, K. HayGlass, R. C. Brunham, and L. Babiuk. Aggregate content influences the Th1\/Th2 immune response to influenza vaccine: Evidence from a mouse model. J. Med. Virol. 72:138\u2013142 (2004).","journal-title":"J. Med. Virol."},{"key":"9559_CR122","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.vaccine.2004.06.041","volume":"23","author":"H. J. Dean","year":"2004","unstructured":"H. J. Dean, and D. Chen. Epidermal powder immunization against influenza. Vaccine 23:681\u2013686 (2004).","journal-title":"Vaccine"},{"key":"9559_CR123","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000234034","volume":"80","author":"K. C. Bergmann","year":"1986","unstructured":"K. C. Bergmann, R. H. Waldman, H. Tischner, and W. D. Pohl. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine. Int. Arch. Allergy Appl. Immunol. 80:107\u2013109 (1986).","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"9559_CR124","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1023\/A:1024493719236","volume":"20","author":"Y. F. Maa","year":"2003","unstructured":"Y. F. Maa, C. Shu, M. Ameri, C. Zuleger, J. Che, J. E. Osorio, L. G. Payne, and D. Chen. Optimization of an alum-adsorbed vaccine powder formulation for epidermal powder immunization. Pharm. Res. 20:969\u2013977 (2003).","journal-title":"Pharm. Res."},{"key":"9559_CR125","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1128\/JVI.75.17.7956-7965.2001","volume":"75","author":"D. Chen","year":"2001","unstructured":"D. Chen, S. B. Periwal, K. Larrivee, C. Zuleger, C. A. Erickson, R. L. Endres, and L. G. Payne. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J. Virol. 75:7956\u20137965 (2001).","journal-title":"J. Virol."},{"key":"9559_CR126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2004.02.027","volume":"103","author":"D. Chen","year":"2004","unstructured":"D. Chen, M. Burger, Q. Chu, R. Endres, C. Zuleger, H. Dean, and L. G. Payne. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res. 103:147\u2013153 (2004).","journal-title":"Virus Res."},{"key":"9559_CR127","unstructured":"The European Agency for the Evaluation of Medicinal Products (EMEA) Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on Harmonization of Requirements for Influenza Vaccines. CPMP\/BWP\/214\/96 (1997)."},{"key":"9559_CR128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1517\/17425247.3.1.87","volume":"3","author":"V. J. Sullivan","year":"2006","unstructured":"V. J. Sullivan, J. A. Mikszta, P. Laurent, J. Huang, and B. Ford. Noninvasive delivery technologies: Respiratory delivery of vaccines. Expert Opin. Drug Deliv. 3:87\u201395 (2006).","journal-title":"Expert Opin. Drug Deliv."},{"key":"9559_CR129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","volume":"29","author":"M. T. Vidgren","year":"1998","unstructured":"M. T. Vidgren, and H. Kublik. Nasal delivery systems and their effect on deposition and absorption. Adv. Drug Deliv. Rev. 29:157\u2013177 (1998).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9559_CR130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i1.20","volume":"21","author":"S. P. Newman","year":"2004","unstructured":"S. P. Newman, G. R. Pitcairn, and R. N. Dalby. Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit. Rev. Ther. Drug Carrier Syst. 21:21\u201366 (2004).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"9559_CR131","first-page":"1161","volume":"50","author":"B. L. Laube","year":"2005","unstructured":"B. L. Laube. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination. Respir. Care 50:1161\u20131176 (2005).","journal-title":"Respir. Care"},{"key":"9559_CR132","unstructured":"Pulmonary drug delivery, Editio Cantor Verlag f\u00fcr Medizin und Naturwissenschaften GmbH, Aulendorf, 2007."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-008-9559-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:09:12Z","timestamp":1684285752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-008-9559-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,13]]},"references-count":132,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9559"],"URL":"https:\/\/doi.org\/10.1007\/s11095-008-9559-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,13]]}}}